60 Degrees Pharmaceuticals, Inc.
SXTP
$0.95
-$0.02-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 207.90K | 162.10K | 316.40K | 528.60K | 307.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 207.90K | 162.10K | 316.40K | 528.60K | 307.90K |
| Cost of Revenue | 749.80K | 367.20K | 759.60K | 1.35M | 282.00K |
| Gross Profit | -541.90K | -205.10K | -443.20K | -818.90K | 25.90K |
| SG&A Expenses | 1.73M | 1.89M | 1.47M | 1.51M | 1.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.48M | 2.26M | 2.23M | 2.85M | 1.91M |
| Operating Income | -2.27M | -2.10M | -1.92M | -2.33M | -1.61M |
| Income Before Tax | -2.27M | -2.09M | -1.44M | -2.32M | -1.73M |
| Income Tax Expenses | -- | -- | -1.80K | 300.00 | -- |
| Earnings from Continuing Operations | -2.27M | -2.09M | -1.44M | -2.32M | -1.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.10K | 900.00 | 500.00 | 700.00 | 1.20K |
| Net Income | -2.26M | -2.09M | -1.44M | -2.32M | -1.73M |
| EBIT | -2.27M | -2.10M | -1.92M | -2.33M | -1.61M |
| EBITDA | -2.24M | -2.07M | -1.89M | -2.30M | -1.59M |
| EPS Basic | -0.90 | -1.28 | -1.47 | -2.66 | -5.05 |
| Normalized Basic EPS | -0.53 | -0.76 | -0.84 | -1.58 | -2.94 |
| EPS Diluted | -0.90 | -1.28 | -1.47 | -2.66 | -5.05 |
| Normalized Diluted EPS | -0.53 | -0.76 | -0.84 | -1.58 | -2.94 |
| Average Basic Shares Outstanding | 2.65M | 1.73M | 1.07M | 918.90K | 368.30K |
| Average Diluted Shares Outstanding | 2.65M | 1.73M | 1.07M | 918.90K | 368.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |